← Leaderboards
Alain C Borczuk
Weill Medical Coll Of Cornell Univ
$997,395
Attributed
$4,986,977
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2019–23$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,986,977 · 2
By mechanism
UH3$2,932,940 · 1
UG3$2,054,037 · 1
Top collaborators
- Nasser Khaled Altorki9 shared
- Olivier Elemento9 shared
- Timothy E Mcgraw9 shared
- Vivek Mittal9 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Steven Monroe Lipkin$27,661,021
- Nasser Khaled Altorki$2,970,612
- Vivek Mittal$10,850,597
- Olivier Elemento$10,592,678
- Fernando J Martinez$34,787,404
Others in their field
Other Emerging Leaders on “Imaging Modality”
- Stephen F Kry · University Of Tx Md Anderson Can Ctr$28,888,963
- Andrew Shoffstall · Louis Stokes Cleveland Va Medical Center$15,790,088
- Carla M Bann · Research Triangle Institute$11,818,358
- Jacqueline K White · Jackson Laboratory$11,663,450
- Nuno Macarico Da Costa · Allen Institute$11,605,392
- Dana L Tudorascu · University Of Pittsburgh At Pittsburgh$11,503,738
Research focus
Imaging ModalityInterceptHistologicImageImmunofluorescence ImmunologicInsightGlobal HealthHigh RiskAdenocarcinomaHistologyImmuneImmune TargetingCatalogsIndolentAgreementFutureBiologyCohortCancer CellComparativeCancer InvasivenessEventDisease ProgressionLesion
Grant awards (9)
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$805,881
UH3 · FY2023 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$234,178
UH3 · FY2023 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$808,655
UH3 · FY2022 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$238,958
UH3 · FY2022 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$845,268
UH3 · FY2021 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$249,999
UG3 · FY2021 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$836,730
UG3 · FY2020 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$130,578
UG3 · FY2020 · CA
Intercepting progression from pre-invasive to invasive lung adenocarcinoma$836,730
UG3 · FY2019 · CA